GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.
|
Synonyms: Melflufen | Pepaxti® | Pepaxto® | Prodrug J 1 | Prodrug J-1
melphalan flufenamide is an approved drug (FDA (2021), EMA (2022))
Compound class:
Synthetic organic
Comment: Melphalan flufenamide is a peptide-conjugated prodrug of the cytotoxic DNA alkylating drug melphalan [3]. It is highly lipophilic and is rapidly transported into cells where it is quickly hydrolysed by aminopeptidases that are overexpressed by some cancer cells. Melphalan flufenamide is being evaluated as a treatment for multiple myeloma [2,5-6].
The IUPAC Condensed peptide sequence for melphalan flufenamide is H-Phe(Unk)-Phe(4-F)-OEt. |
|
|||||||||||||||||||||||||||||||||||
Classification ![]() |
|
| Compound class | Synthetic organic |
| Approved drug? | Yes. EU EMA (2022) | US FDA (2021) |
| Is prodrug? | Yes |
| Active form | melphalan |
IUPAC Name ![]() |
| ethyl (2S)-2-[[(2S)-2-amino-3-[4-[bis(2-chloroethyl)amino]phenyl]propanoyl]amino]-3-(4-fluorophenyl)propanoate |
International Nonproprietary Names ![]() |
|
| INN number | INN |
| 9493 | melphalan flufenamide |
Synonyms ![]() |
| Melflufen | Pepaxti® | Pepaxto® | Prodrug J 1 | Prodrug J-1 |
Database Links ![]() |
|
| CAS Registry No. | 380449-51-4 (source: WHO INN record) |
| ChEMBL Ligand | CHEMBL4303060 |
| GtoPdb PubChem SID | 442878639 |
| PubChem CID | 9935639 |
| Search Google for chemical match using the InChIKey | YQZNKYXGZSVEHI-VXKWHMMOSA-N |
| Search Google for chemicals with the same backbone | YQZNKYXGZSVEHI |
| Search PubMed clinical trials | melphalan flufenamide |
| Search PubMed titles | melphalan flufenamide |
| Search PubMed titles/abstracts | melphalan flufenamide |
| UniChem Compound Search for chemical match using the InChIKey | YQZNKYXGZSVEHI-VXKWHMMOSA-N |
| UniChem Connectivity Search for chemical match using the InChIKey | YQZNKYXGZSVEHI-VXKWHMMOSA-N |